Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery

With the recent global surge of SARS-CoV-2 Delta variant, there continues to be high demand for COVID-19 diagnostic testing. Abbott ID NOW is a rapid, CLIA-waived, COVID-19 diagnostic test ideally suited for use in urgent care settings or where access to diagnostic testing is limited. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Babic, N., Garner, K.S., Hirschhorn, J.W., Zebian, R., Nolte, F.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653396/
https://www.ncbi.nlm.nih.gov/pubmed/34896098
http://dx.doi.org/10.1016/j.clinbiochem.2021.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653396/
https://www.ncbi.nlm.nih.gov/pubmed/34896098
http://dx.doi.org/10.1016/j.clinbiochem.2021.12.003

Ejemplares similares